Company Filing History:
3 out of 2,928 
1 out of 1,153 
Years Active: 2018-2021
Title: Jamal Lewis: Innovator in Immunotherapy
Introduction
Jamal Lewis is a prominent inventor based in Tallahassee, FL (US), known for his contributions to the field of immunotherapy. With a total of 3 patents, he has made significant strides in developing innovative solutions for immune diseases and autoimmune disorders.
Latest Patents
One of his latest patents is titled "Antigen-specific, tolerance-inducing microparticles and uses thereof." This invention provides antigen-specific, tolerance-inducing microparticles designed for the targeted delivery of therapeutic agents to immune cells. It also allows for the sustained release of these agents over a prolonged period, offering therapeutic uses for the prevention and treatment of immune diseases, including type 1 diabetes. Another notable patent is "Polymeric particles, method for cytosolic delivery of cargo, methods of making the particles." This patent encompasses particles, methods for creating them, and techniques for delivering active agents using these particles.
Career Highlights
Jamal Lewis has worked with esteemed institutions such as the University of Florida Research Foundation and Vanderbilt University. His work in these organizations has contributed to advancing research in immunotherapy and related fields.
Collaborations
He has collaborated with notable colleagues, including Benjamin George Keselowsky and Abhinav Prakash Acharya, further enhancing the impact of his research and inventions.
Conclusion
Jamal Lewis continues to be a significant figure in the realm of immunotherapy, with his innovative patents paving the way for new treatments for immune-related conditions. His work exemplifies the importance of research and collaboration in advancing medical science.